CAS: 125068-54-4 - NSP 805
Formel:C17H19N3O2
InChl:InChI=1/C17H19N3O2/c1-10-9-16(22)19-20-17(10)12-3-5-13(6-4-12)18-14-7-8-15(21)11(14)2/h3-6,10,18H,7-9H2,1-2H3,(H,19,22)
- Synonyme:
- 4,5-Dihydro-5-methyl-6-(4-((2-methyl-3-oxo-1-cyclopentenyl)amino)phenyl)-3-(2H)-pyridazinone
- 3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-(4-((2-methyl-3-oxo-1-cyclopenten-1-yl)amino)phenyl)-
- 5-methyl-6-{4-[(2-methyl-3-oxocyclopent-1-en-1-yl)amino]phenyl}-4,5-dihydropyridazin-3(2H)-one
- Nsp-805
- Nsp 805
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
NSP-805 REF: TM-T12267CAS: 125068-54-4 | 99.10% | 51,00 €~2.124,00 € | Do 02 Jan 25 | |
3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-[4-[(2-methyl-3-oxo-1-cyclopenten-1-yl)amino]phenyl]- REF: IN-DA000N32CAS: 125068-54-4 | 99% | Nachfragen | Do 02 Jan 25 | |
NSP-805 REF: 3D-AFA06854CAS: 125068-54-4 | Min. 95% | Nachfragen | Di 11 Feb 25 |
NSP-805
CAS:125068-54-4
NSP-805 is a potent and selective guinea pig cardiac phosphodiesterase 3 (PDE3) inhibitor.
Formel:
C17H19N3O2
Reinheit:
99.10%
Farbe und Form:
Solid
Molekulargewicht:
297.35
Ref: TM-T12267
1mg | 51,00 € | ||
5mg | 112,00 € | ||
10mg | 181,00 € | ||
25mg | 315,00 € | ||
50mg | 450,00 € | ||
100mg | 621,00 € | ||
200mg | 840,00 € | ||
1mL*10mM (DMSO) | 124,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 2. Januar 2025
3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-[4-[(2-methyl-3-oxo-1-cyclopenten-1-yl)amino]phenyl]-
CAS:125068-54-4
Formel:
C17H19N3O2
Reinheit:
99%
Farbe und Form:
Solid
Molekulargewicht:
297.3517
Ref: IN-DA000N32
1mg | 149,00 € | ||
5mg | 316,00 € | ||
10mg | 506,00 € | ||
25mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 2. Januar 2025
NSP-805
CAS:125068-54-4
NSP-805 is a calcium antagonist with inotropic and vasodilatory properties. It has been shown to …
Formel:
C17H19N3O2
Reinheit:
Min. 95%
Molekulargewicht:
297.35 g/mol
Ref: 3D-AFA06854
25mg | Nachfragen | ||
50mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 11. Februar 2025